Engineered oncolytic virus armed w immune-stimulating transgenes for patients w solid tumors. Ph 1 and Ph 1/2 trials ongoing with multiple data readouts in 2018 and 2019. CMO developed Yervoy at BMS.
Send Message to Request Information
Log in to download presentation, request a 1x1 meeting, view additional roadshows, and more.
Stock Market Data
Market Data copyright © 2017 QuoteMedia.
Data delayed 15 minutes unless otherwise indicated (view
delay times for all
exchanges). RT=Real-Time, RTB=Real-Time
BATS BZX Price/Quote; not sourced from all markets, RTN=Real-Time
NASDAQ Basic+ Price/Quote; not sourced from all markets, EOD=End of
Day, PD=Previous Day. Market Data powered by